ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #5,448Hybrid

Journal of Neuroimmunology

Acronym:jnimm
•
Abbreviation (ISO):J NEUROIMMUNOL
•
Identifier (ISSN):0165-5728(Print)/1872-8421(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
3.1↑ +0.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Neuroimmunology

WoS Q3
12452.6520182.8320193.1320203.4820213.2220223.320232.920242.520253.12026
Annual Impact Factor Metric
Current (2026):3.1
Scopus SJR & RankScopus Q2
0.938
#5,448

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
163

163 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
239articles/year
17.55% Gold OA•85.51% Original Research

Aims & Scope

The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication.

Topics Covered (Recognized by AI)
Medicine91.9%Biology91.9%Immunology83.1%Genetics80.6%Internal medicine78.5%Psychology69.2%Chemistry64.6%Biochemistry61.1%Neuroscience50.3%Endocrinology49.2%Psychiatry47.6%Pathology45.8%Immune system42.1%Multiple sclerosis30%Antibody28.1%Central nervous system27.2%Inflammation25.6%Disease25.4%Receptor24.3%Gene23.9%Antigen21.9%Cell biology21.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank108/183
IndexSCIE
JCRSCIE2026

NEUROSCIENCES

Q3
Rank172/330
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank101/183
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q3
Rank210/330
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.1
Articles / Year184
Total Citations49
2025
IF2.5
Articles / Year252
Total Citations524
2024
IF2.9
Articles / Year155
Total Citations746
2023
IF3.3
Articles / Year175
Total Citations1,711
2022
IF3.221
Articles / Year145
Total Citations1,543

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,448Scopus Q2SCImago Profile
Scopus Coverage:1981-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicineNeuroscience
Scopus Citation Rank (SJR)Q2
0.938

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.08

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,264 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,387
3-Year Documents448
Citable Documents432

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2
Immunology and AllergyQ2
NeurologyQ2
Neurology (clinical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Neuroimmunology (acronym: jnimm, abbr: J NEUROIMMUNOL, ISSN: 0165-5728) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.938 (Q2), an H-index of 163.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 239 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,264 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
English
Frequency
Monthly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: eb91065b-1cdd-45fe-83a0-2ba051b821cd
Database Updated: 2026-10-16